Bridging the Bench-to-Bedside Gap with Multimodal Artificial Intelligence in Digestive Diseases

Livers, vol. 6, pp. 1

Abstract

This comment discusses a recent review by Wu and colleagues on multimodal artificial intelligence in gastroenterology and hepatology. The review outlined advancements in endoscopic, radiomics, pathologic, and multi-omics technologies. Additionally, it highlights persistent barriers, such as data heterogeneity, “black box” opacity, reimbursement uncertainty, and third-party data security risks. The comment also discusses current payment models for autonomous algorithms and emphasizes the importance of robust governance frameworks. Beyond summarizing recent progress, this commentary proposes a pragmatic, five-point roadmap to facilitate the safe and fair deployment of multimodal artificial intelligence in digestive disease care in the future, including standardization, explainability, federated governance, equitable reimbursement, and sustainability metrics. By implementing these action items, stakeholders can transform promising algorithms into clinically validated, workflow-compatible, and economically viable tools.

Authors 1

1. Ralf Weiskirchen corresponding Aachen Institute of Molecular Pathobiochemistry Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC)

   RWTH Aachen University · Universitätsklinikum Aachen

   Affiliation as printed

   Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany